Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

Figure 1

The renal effects of amlodipine and telmisartan/amlodipine SPC. UACR changes after 8 weeks' treatment with the telmisartan/amlodipine SPC or amlodipine monotherapy in diabetic, hypertensive patients [107]. Abbreviations: SPC = single-pill combination; T/A = telmisartan/amlodipine; UACR = urine albumin-to-creatinine ratio.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840